Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	24.84	37.35	29.92
Graham Fair Price	0.21	77.09	76.93
PEG	-270.98	-1.48	-0.40
Price/Book	12.73	0.80	0.71
Price/Cash Flow	-60.31	24.60	61.97
Prices/Earnings	23.30	6.45	5.23
Price/Sales	32.04	2.14	1.62
Price/FCF	-60.31	24.60	61.97
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.07	0.20	0.20
Operating Margin	-9.90	0.08	0.09
ROA	-6.06	0.01	0.01
ROE	0.03	0.03	-8.57
ROIC	0.01	< 0.005	-19.26
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.27	-97.89
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.30	-0.20	33.50
EPS QOQ	-0.13	-0.04	66.76
FCF QOQ	-0.26	1.96	644.40
Revenue QOQ	0.08	-0.11	32.45
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	76.10	91.00	19.58
Days Sales Outstanding (DSO)	110.32	112.51	1.98
Inventory Turnover	1.18	0.99	-16.38
Debt/Capitalization	0.54	0.53	-2.28
Quick Ratio	0.87	0.87	0.46
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	88.00	92.23	4.81
Cash	21.21	23.00	8.45
Capex	-2.44	-1.39	43.03
Free Cash Flow	1.01	3.00	197.67
Revenue	38.61	34.55	-10.51
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.26	1.35	7.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.57	20.25	15.30
Naive Interpretation	Member

06 - Financial Health · Weak

Rating